These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29843087)

  • 61. Non-vitamin K oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolic disease.
    Voukalis C; Lip GY; Shantsila E
    Expert Opin Pharmacother; 2016 Oct; 17(15):2033-47. PubMed ID: 27667112
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [New oral anticoagulants for treatment of venous thromboembolism].
    Espinola-Klein C; Weisser G
    Dtsch Med Wochenschr; 2011 Jun; 136(22):1162-4. PubMed ID: 21611919
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative effectiveness and safety of direct oral anticoagulants (DOACs) versus conventional anticoagulation for the treatment of cancer-related venous thromboembolism: A retrospective analysis.
    Ross JA; Miller MM; Rojas Hernandez CM
    Thromb Res; 2017 Feb; 150():86-89. PubMed ID: 28064037
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The impact of oral anticoagulation on time to surgery in patients hospitalized with hip fracture.
    Tran T; Delluc A; de Wit C; Petrcich W; Le Gal G; Carrier M
    Thromb Res; 2015 Nov; 136(5):962-5. PubMed ID: 26428416
    [TBL] [Abstract][Full Text] [Related]  

  • 65. New oral anticoagulants in the treatment of acute venous thromboembolism - a systematic review with indirect comparisons.
    Hirschl M; Kundi M
    Vasa; 2014 Sep; 43(5):353-64. PubMed ID: 25147012
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Direct Oral Anticoagulants versus Vitamin K Antagonists in Individuals Aged 80 Years and Older: An Overview in 2021.
    Azzoug C; Nuémi G; Menu D; De Maistre E; Boulin M; Putot A; Manckoundia P
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674204
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions.
    Riess H; Prandoni P; Harder S; Kreher S; Bauersachs R
    Crit Rev Oncol Hematol; 2018 Dec; 132():169-179. PubMed ID: 30447923
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of the Direct Oral Anticoagulants for the Treatment of Venous Thromboembolism.
    Riva N; Ageno W
    Hematol Oncol Clin North Am; 2016 Oct; 30(5):1035-51. PubMed ID: 27637306
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The impact of direct oral anticoagulants in traumatic brain injury patients greater than 60-years-old.
    Prexl O; Bruckbauer M; Voelckel W; Grottke O; Ponschab M; Maegele M; Schöchl H
    Scand J Trauma Resusc Emerg Med; 2018 Mar; 26(1):20. PubMed ID: 29580268
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?
    Verso M; Franco L; Giustozzi M; Becattini C; Agnelli G
    Thromb Res; 2018 Apr; 164 Suppl 1():S168-S171. PubMed ID: 29703477
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The Novel Oral Anticoagulants for Acute Venous Thromboembolism: Is Warfarin Dead?
    Cohen AT; Granziera S; Veronese N; Zoppellaro G
    Semin Respir Crit Care Med; 2017 Feb; 38(1):29-39. PubMed ID: 28208196
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Safety ad efficacy of direct oral anticoagulants for extended treatment of venous thromboembolism.
    Imberti D; Pomero F; Benedetti R; Fenoglio L
    Intern Emerg Med; 2016 Oct; 11(7):895-900. PubMed ID: 27550399
    [TBL] [Abstract][Full Text] [Related]  

  • 73. How I treat pediatric venous thromboembolism in the DOAC era.
    Bhat RV; Young G; Sharathkumar AA
    Blood; 2024 Feb; 143(5):389-403. PubMed ID: 37390311
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists.
    Brekelmans MP; Bleker SM; Bauersachs R; Boda Z; Büller HR; Choi Y; Gallus A; Grosso MA; Middeldorp S; Oh D; Raskob G; Schwocho L; Cohen AT
    Thromb Haemost; 2016 Jul; 116(1):155-61. PubMed ID: 27010092
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns.
    Toorop MMA; van Rein N; Nierman MC; Vermaas HW; Huisman MV; van der Meer FJM; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2020 Jun; 18(6):1390-1397. PubMed ID: 32170987
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature.
    Dentali F; Sironi AP; Gianni M; Orlandini F; Guasti L; Grandi AM; Franchini M; Ageno W; Squizzato A
    Semin Thromb Hemost; 2015 Oct; 41(7):774-87. PubMed ID: 26408921
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Initiation of direct oral anticoagulants versus warfarin for venous thromboembolism: impact on time to hospital discharge.
    Basto AN; Fewel NP; Vo K; Stock EM; Ta M
    J Thromb Thrombolysis; 2018 Jan; 45(1):51-55. PubMed ID: 29086244
    [TBL] [Abstract][Full Text] [Related]  

  • 78. What have we learned from real-world NOAC studies in venous thromboembolism treatment?
    Beyer-Westendorf J
    Thromb Res; 2018 Mar; 163():83-91. PubMed ID: 29407632
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Compliance to perioperative anticoagulation protocols in elderly patients undergoing elective orthopedic procedures: a retrospective observational cohort study on 548 patients.
    Munk L; van Essen T; van der Hoeven C; Nolte PA; Becker ML
    Patient Saf Surg; 2023 Apr; 17(1):9. PubMed ID: 37081479
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety and efficacy of direct oral anticoagulants compared to warfarin for extended treatment of venous thromboembolism -a systematic review and meta-analysis.
    Sindet-Pedersen C; Pallisgaard JL; Olesen JB; Gislason GH; Arevalo LC
    Thromb Res; 2015 Oct; 136(4):732-8. PubMed ID: 26277682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.